Insights

Vaccine Variants Novavax is actively developing COVID-19 vaccines for variants, presenting a sales opportunity to cater to evolving needs in the market and ensure ongoing protection against emerging strains.

Flu-COVID Combo Shots With a focus on next-generation flu-COVID-19 combination shots, Novavax's partnership with Sanofi opens avenues for cross-selling opportunities, offering customers a comprehensive solution to combat multiple respiratory illnesses.

Pharmaceutical Financing Having secured substantial financing and licensing agreements, Novavax is in a strong financial position to expand its product portfolio, making it a promising partner for collaborations and joint ventures within the pharmaceutical industry.

Cutting-edge Technology Utilizing a tech stack that includes cloud services like Microsoft Azure and a robust data management system with MongoDB, Novavax demonstrates readiness to engage with tech-savvy clients seeking innovative solutions in vaccine development.

Market Expansion Through partnerships and agreements focused on vaccine development and commercialization, Novavax is positioning itself for market expansion, making it an appealing prospect for clients looking to tap into new growth opportunities in the healthcare sector.

Similar companies to Novavax

Novavax Tech Stack

Novavax uses 8 technology products and services including Cloudflare CDN, MongoDB, Microsoft PowerPoint, and more. Explore Novavax's tech stack below.

Cloudflare CDN
Content Delivery Network
MongoDB
Database
Microsoft PowerPoint
Editors
Google Charts
Javascript Graphics
Windows Server
Operating Systems
Microsoft Azure
Platform As A Service
Kinaxis
Supply Chain Management
Adobe Tag Manager
Tag Management

Media & News

Novavax's Email Address Formats

Novavax uses at least 1 format(s):

Novavax Email Formats	Example	Percentage
FLast@novavax.com	JDoe@novavax.com	92%
FirstLast@novavax.com	JohnDoe@novavax.com	4%
First.Last@novavax.com	John.Doe@novavax.com	2%
FirstLa@novavax.com	JohnDo@novavax.com	2%

Frequently Asked Questions

Where is Novavax's headquarters located?

Novavax's main headquarters is located at 700 Quince Orchard Rd Gaithersburg, Maryland 20878 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Novavax's phone number?

You can contact Novavax's main corporate office by phone at

+1-240-268-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novavax's stock symbol?

Novavax is a publicly traded company; the company's stock symbol is NVAX.

What is Novavax's official website and social media links?

Novavax's official website is novavax.com and has social profiles on LinkedIn.

How much revenue does Novavax generate?

As of August 2024, Novavax's annual revenue reached $5B.

What is Novavax's NAICS code?

Novavax's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novavax have currently?

As of August 2024, Novavax has approximately 1.2K employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Strategy Officer, Business Development And Alliances: E. O.Chief Operations Officer: R. C.Chief Accounting Officer (cao): T. S.. Explore Novavax's employee directory with LeadIQ.

What industry does Novavax belong to?

Novavax operates in the Pharmaceutical Manufacturing industry.

What technology does Novavax use?

Novavax's tech stack includes Cloudflare CDNMongoDBMicrosoft PowerPointGoogle ChartsWindows ServerMicrosoft AzureKinaxisAdobe Tag Manager.

What is Novavax's email format?

Novavax's email format typically follows the pattern of . Find more Novavax email formats with LeadIQ.

How much funding has Novavax raised to date?

As of August 2024, Novavax has raised $85M in funding. The last funding round occurred on Aug 08, 2023 for $85M.

When was Novavax founded?

Novavax was founded in 1987.

Novavax

Pharmaceutical ManufacturingMaryland, United States1001-5000 Employees

We’re making a difference in the health of people around the world by producing next generation vaccines that are accessible to more people. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our hopes. We do this work for the greater health of people everywhere. It’s more than our job. It’s our passion.

Our Novavax Social Community Guidelines: https://www.novavax.com/social-media-community-guidelines

Company Overview

Headquarters: 700 Quince Orchard Rd Gaithersburg, Maryland 20878 US
Phone number: ✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-240-268-****
Website: novavax.com
Stock Symbol: NVAX
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Founded: 1987
Employees: 1001-5000

Media & News

Funding & Financials

$85M
Novavax has raised a total of $85M of funding over 10 rounds. Their latest funding round was raised on Aug 08, 2023 in the amount of $85M.
$1B
Novavax's revenue is in the range of $1B

Funding & Financials

$85M
Novavax has raised a total of $85M of funding over 10 rounds. Their latest funding round was raised on Aug 08, 2023 in the amount of $85M.
$1B
Novavax's revenue is in the range of $1B

Company Leadership

E. O.
Chief Strategy Officer, Business Development And Alliances
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. C.
Chief Operations Officer
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. S.
Chief Accounting Officer (cao)
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. S.
Vice President Of Global Business Development
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. T.
Vice President - Market Access, Trade & Distribution
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. T.
President, Chief Operating Officer
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C. J.
President, Ceo And Member Of The Board Of Directors
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. C.
Chief Operations Officer
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. W.
Senior Vice President And Chief Medical Officer
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. K.
Evp & Chief Financial Officer
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Novavax and Millions of Other Companies
Sign up for full access to Novavax information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Novavax

Merck

Sanofi

Emergent BioSolutions

Roche

Johnson & Johnson

Moderna

AstraZeneca

CureVac

Gilead Sciences

Novartis

Pfizer

AbbVie

Novavax Tech Stack

Media & News

Novavax, Inc will develop COVID-19 vaccine for variants on Jan 1st '26.

Novavax, Inc is developing JN.1 booster vaccine.

Novavax, Inc is developing next-generation flu-COVID-19 combination shot.

Novavax, Inc is developing COVID-flu combo vaccine.

Novavax, Inc receives financing of $1.2B in equity investment.

Novavax, Inc is developing life-saving vaccines to fight infectious diseases. on May 10th '24.

Novavax, Inc is developing COVID-19-Influenza Combination vaccine candidate.

Novavax's Email Address Formats

Frequently Asked Questions

Where is Novavax's headquarters located?

What is Novavax's phone number?

What is Novavax's stock symbol?

What is Novavax's official website and social media links?

How much revenue does Novavax generate?

What is Novavax's NAICS code?

How many employees does Novavax have currently?

What industry does Novavax belong to?

What technology does Novavax use?

What is Novavax's email format?

How much funding has Novavax raised to date?

When was Novavax founded?

Novavax

Company Overview

Media & News

Novavax, Inc will develop COVID-19 vaccine for variants on Jan 1st '26.

Novavax, Inc is developing JN.1 booster vaccine.

Novavax, Inc is developing next-generation flu-COVID-19 combination shot.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?